TherapeuticsMD

(NASDAQ) TXMD

Current Price$2.09

Market Cap$23.50M

Since IPO (2011)-96%

5 Year-96%

1 Year+80%

1 Month+0%

TherapeuticsMD Financials at a Glance

Market Cap

$23.50M

Revenue (TTM)

$3.35M

Net Income (TTM)

$179.00K

EPS (TTM)

$0.02

P/E Ratio

131.82

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$2.09

Volume

50,904.685

Open

$2.01

Price

$2.09

Volume

50,904.685

Open

$2.01

Previous Close

$2.11

Daily Range

$2.01 - $2.15

52-Week Range

$0.98 - $2.95

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$2.09

Volume

50,904.685

Open

$2.01

Previous Close

$2.11

Daily Range

$2.01 - $2.15

52-Week Range

$0.98 - $2.95

Estimated Earnings Date

Aug 17, 2026

TXMD News

TherapeuticsMD Swings to Profit in Q2

Motley Fool Markets TeamAug 12, 2025

3 Awful Stocks Robinhood Investors Love -- and 1 of the Best

James HalleyAug 19, 2020

3 Drug Stocks That Could Soar in 2020

Amar KhatriJun 10, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TherapeuticsMD

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Marlan D. Walker

Website

www.therapeuticsmd.com

Headquarters

Boca Raton, FL 33431, US

TXMD Financials

Key Financial Metrics (TTM)

Gross Margin

90.31%

Operating Margin

-111.66%

Net Income Margin

5.34%

Return on Equity

0.66%

Return on Capital

-12.78%

Return on Assets

0.48%

Earnings Yield

0.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$23.50M

Shares Outstanding

11.57M

Volume

50.90K

Avg. Volume

36.44K

Financials (TTM)

Gross Profit

$3.03M

Operating Income

-$3.74M

EBITDA

-$3.71M

Operating Cash Flow

$2.67M

Capital Expenditure

$0.00

Free Cash Flow

$2.67M

Cash & ST Invst.

$8.42M

Total Debt

$5.83M

TherapeuticsMD Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$724.00K

+84.2%

Gross Profit

$399.00K

+1.5%

Gross Margin

55.11%

N/A

Market Cap

$23.50M

N/A

Market Cap/Employee

$23.50M

N/A

Employees

N/A

Net Income

$95.00K

+114.5%

EBITDA

-$398.00K

+63.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$8.42M

+46.5%

Total Debt

$5.83M

-16.4%

Accounts Receivable

$3.21M

+7.2%

Inventory

$0.00

N/A

Long Term Debt

$4.82M

-19.1%

Short Term Debt

$1.01M

-0.4%

Return on Assets

0.48%

N/A

Return on Invested Capital

-11.46%

N/A

Free Cash Flow

$936.00K

+36.4%

Operating Cash Flow

$936.00K

+36.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MPLTMapLight Therapeutics, Inc.

MPLTMapLight Therapeutics, Inc.$33.28+4.13%

AYTUAytu BioPharma, Inc.

AYTUAytu BioPharma, Inc.$2.17+0.00%

PMNProMIS Neurosciences, Inc.

PMNProMIS Neurosciences, Inc.$10.53+2.73%

BFRIBiofrontera Inc.

BFRIBiofrontera Inc.$0.97+2.58%

GELSGelteq Limited Ordinary Shares

GELSGelteq Limited Ordinary Shares$0.62+3.30%

ERNAErnexa Therapeutics Inc.

ERNAErnexa Therapeutics Inc.$6.97-5.81%

PRPHProPhase Labs, Inc.

PRPHProPhase Labs, Inc.$0.10+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

NWLNewell Brands

NWLNewell Brands$5.82-0.01%

WENWendy's

WENWendy's$7.80+0.06%

Questions About TXMD

What is the current price of TherapeuticsMD?

TherapeuticsMD is trading at $2.11 per share.

What is the 52-week range for TherapeuticsMD?

Over the past 52 weeks, TherapeuticsMD has traded between $0.98 and $2.95.

How much debt does TherapeuticsMD have?

As of the most recent reporting period, TherapeuticsMD reported total debt of $5.83M.

How much cash does TherapeuticsMD have on hand?

TherapeuticsMD reported $8.42M in cash and cash equivalents in its most recent financial results.

What is TherapeuticsMD’s dividend yield?

TherapeuticsMD does not currently have a dividend yield.

TherapeuticsMD

TherapeuticsMD Financials at a Glance

TXMD News

TherapeuticsMD Swings to Profit in Q2

3 Awful Stocks Robinhood Investors Love -- and 1 of the Best

3 Drug Stocks That Could Soar in 2020

Here's Why TherapeuticsMD Stock Is Rocketing Higher Today

Is TherapeuticsMD Stock a Buy?

Why TherapeuticsMD's Stock Jumped Today

Here's Why TherapeuticsMD Fell as Much as 21.5% Today

Here's Why TherapeuticsMD Jumped 25.6% in September

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About TherapeuticsMD

TXMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

TherapeuticsMD Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TXMD

What is the current price of TherapeuticsMD?

What is the 52-week range for TherapeuticsMD?

How much debt does TherapeuticsMD have?

How much cash does TherapeuticsMD have on hand?

What is TherapeuticsMD’s dividend yield?

Premium Investing Services